You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Insulin Articles
Popular Insulin Articles
Highly Recommended Insulin Articles
Send a link to this page to your friends and colleagues.
The results of the study were published in the March 2 issue of the Annals of Internal Medicine. Finnish investigators report the results of a direct comparison of four bedtime insulin regimens that were randomly assigned to 96 patient with type 2 diabetes. The patients had previously been treated by sulfonylurea therapy alone, and had demonstrated an average HbA1c of 9.9 % and an average BG reading of 214.5 mg/dl.
For 12 months, the 96 patients took a combination of either: (1) bedtime intermediate-acting insulin plus glyburide (10.5 mg.) and placebo, (2) metformin (2 grams) and placebo, (3) glyburide and metformin, or (4) a second injection of intermediate-acting insulin in the morning.
After 13 months, the group taking the combination of intermediate-acting insulin and metformin demonstrated the greatest decrease in HbA1c (9.7 % to 7.2 %). Additionally, this group reported fewer cases of hypoglycemia after one year when compared to the other groups.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.